Current understanding of nucleoside analogs inhibiting the SARS-CoV-2 RNA-dependent RNA polymerase

Since the outbreak of the COVID-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) has become a main target for antiviral therapeutics due to its essential role in viral replication and transcription. Thus, nucleoside analogs structurally re...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tiantian, Zhang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2023
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498173/
https://www.ncbi.nlm.nih.gov/pubmed/37711189
http://dx.doi.org/10.1016/j.csbj.2023.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498173/
https://www.ncbi.nlm.nih.gov/pubmed/37711189
http://dx.doi.org/10.1016/j.csbj.2023.09.001

Ejemplares similares